Articles

Elon Musk’s chat with Donald Trump could touch on crypto, EVs, the Fed and more

Billionaire entrepreneur Elon Musk has promised “no limits on subject matter” as he speaks with Donald Trump tonight at around 8 p.m. Eastern time.

Kamala Harris to unveil economic platform this week. Here’s what investors will be looking for.

One analyst believes Harris-Walz is “the most progressive ticket” in generations.

Banking stocks for those who worry about a banking crisis

10 banks with low commercial real-estate exposure relative to their total equity

To fix Social Security, increasing the wage base should be part of the solution

Some increase in the wage base is almost inevitable because growing wage inequality has caused the share of wages subject to taxation to decline sharply.

Psychedelic drug contender stocks drop after FDA rejects MDMA treatment

Shares of companies developing treatments based on psilocybin and other psychedelic drugs moved lower on Monday after the U.S. Food and Drug Administration rejected use of MDMA for post-traumatic stress disorder.

As LL Flooring goes bankrupt, here are the 94 stores holding closing sales

LL Flooring, formerly known as Lumber Liquidators, has filed for bankruptcy, which it plans to use to pursue a “going concern” sale of its business.

Dell’s stock is well off its highs. This analyst sees opportunity for investors.

Melius Research is still upbeat about Dell’s earnings potential, though analyst acknowledges the company needs to soothe investors’ margin fears.

Nvidia is one of BofA’s top ‘rebound’ stock picks. Here are the others.

Nvidia’s stock is one of the S&P 500’s best performers in Monday action as BofA outlines why a ‘rebound’ scenario makes sense for the semiconductor sector.

B. Riley Financial’s stock drops 30% after it suspends dividend and projects a loss

Most of B. Riley’s losses are related to the performance of its investment in Franchise Group Inc. — whose retail brands include Vitamin Shoppe, Pet Supplies Plus and furniture seller American Freight — and its Vintage Capital loan receivable.

Ascendis Pharma’s stock surges after FDA approval for first and only treatment for rare disease

The stock of Ascendis Pharma A/S jumped 11% early Monday, after the biotech said the U.S. Food and Drug Administration has approved its Yorvipath as the first and only treatment for a rare endocrine disease.

WeRide sets IPO terms for autonomous-driving company’s U.S. listing

WeRide plans to trade on the Nasdaq under the symbol WRD.

Leveraged funds roll back bets against yen by widest margin in years as carry trade unwinds

A group of trend-following investors active in futures markets has pared its bets against the Japanese yen by the widest margin in years, according to the latest data from the Commodity Futures Trading Commission.
1 923 924 925 926 927 2,360